prednisone,ibrutinib,venetoclax,obinutuzumab,lenalidomide
roche,abbvie,jubilant cadista pharma,janssen
['vipor', 'lymphoma', 'adaptive ']
vipor (veneto-ibru-predn-obi-lena) without maintenance in r/r fl n=30
me prior lines 2 (1-6), 23% refract, 67% pod24
grade 3-4 aes heme &amp; hypokalemia eot mrd- predicts longer pfs molecular relapse predicts clinical relapse -&gt; therapeutic implications? #lymphoma #ash22 
Medical degree at @USAL | Internal Medicine student at @HematoCAUSA | Hematology and Hemotherapy at Hospital Ramón y Cajal @HematoRYC | PhD student at @UAHes